414123001: Erlotinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\...

\Epidermal growth factor receptor inhibitor\Erlotinib (substance)

\Protein-tyrosine kinase inhibitor\Erlotinib (substance)

\Drug or medicament (substance)\Antineoplastic agent (substance)\Epidermal growth factor receptor inhibitor\Erlotinib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Substance with ether structure\Erlotinib (substance)

\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Erlotinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2531730010 Erlotinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2535285016 Erlotinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
75461000195113 Erlotinib de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
25841000188115 Erlotinib fr Synonym (core metadata concept) Inactive Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
809361000172115 erlotinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
60081000195112 erlotinib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erlotinib (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Erlotinib (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Erlotinib (substance)	Has disposition (attribute)	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Erlotinib (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Erlotinib (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Erlotinib (substance)	Is a	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Erlotinib (substance)	Has disposition (attribute)	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Erlotinib (substance)	Is a	éther	false	Inferred relationship	Some
Erlotinib (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing erlotinib (medicinal product)	Has active ingredient	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	Has active ingredient	False	Erlotinib (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	False	Erlotinib (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	False	Erlotinib (substance)	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	False	Erlotinib (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Erlotinib (substance)	Inferred relationship	Some	1
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	Has basis of strength substance (attribute)	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib-containing product in oral dose form	Has active ingredient	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib hydrochloride (substance)	Is modification of (attribute)	True	Erlotinib (substance)	Inferred relationship	Some
Erlotinib only product	Has active ingredient	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib only product in oral dose form	Has active ingredient	True	Erlotinib (substance)	Inferred relationship	Some	1

This concept is not in any reference sets